UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024083
Receipt number R000027723
Scientific Title Safety evaluation study at the using time of household hotpack use
Date of disclosure of the study information 2016/09/16
Last modified on 2017/06/01 14:22:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety evaluation study at the using time of household hotpack use

Acronym

Safety evaluation study of household hotpack use

Scientific Title

Safety evaluation study at the using time of household hotpack use

Scientific Title:Acronym

Safety evaluation study of household hotpack use

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Orthopedics Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety of household hotpac use with healthy adult

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Presence or absence of low-temperature burn

Key secondary outcomes

Abnormality in the skin (discoloration, pain, itching, redness) Abnormality of physical condition


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Put a sample over clothes (underwear, shorts etc) in the lower abdomen more than 8 hours

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

39 years-old >=

Gender

Female

Key inclusion criteria

(1)Japanese
(2)Female
(3)Age:20~39
(At obtaining informed consent)
(4)Subjects giving written informed consent

Key exclusion criteria

(1)Subjects who are judged as unsuitable for the study by the lead principal investigator.
(2)Subjects who use topical cream to under abdomen.
(3)Subjects who get hives and eczema by touching to warm things for a long time.
(4)Subjects who have skin allergy and cutaneous hypersensitivity.
(5)Subjects who are diabetes, disease of hematogenous disorder, hyperhidrosis, other disease of abdomen.
(6)Subjects who have skin symptoms in under abdomen that affect the study. For example, scratch, pimple, verrcura, burn.
(7)Subjects who have a navel piercing and tattoo in under abdomen.
(8)Subjects who go to dermatology.
(9)Subjects who are pregnant, could be pregnant in near future, or is breast feeding.
(10)Subjects who participate in other clinical study.
(11)Subjects who cause skin allergy symptoms (rash, redness, itching etc) by medicine, cosmetics, fomentations, plasters.
(12)Subjects who have a very good or bud warming.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takashi Koikeda

Organization

Shiba Palace Clinic

Division name

hospital director

Zip code


Address

6F Daiwa Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan

TEL

03-5408-1599

Email

jimukyoku@mail.souken-r.com


Public contact

Name of contact person

1st name
Middle name
Last name Reiko Maruya

Organization

SOUKEN Co., Ltd

Division name

Clinical trial management department

Zip code


Address

3F Daiwa Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan

TEL

03-5408-1555

Homepage URL


Email

r_maruya@mail.souken-r.com


Sponsor or person

Institute

SOUKEN Co., Ltd

Institute

Department

Personal name



Funding Source

Organization

Lotte Co., Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 08 Month 31 Day

Date of IRB


Anticipated trial start date

2016 Year 09 Month 20 Day

Last follow-up date


Date of closure to data entry

2017 Year 05 Month 17 Day

Date trial data considered complete

2017 Year 05 Month 24 Day

Date analysis concluded

2017 Year 05 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 09 Month 16 Day

Last modified on

2017 Year 06 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027723


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name